LAD1
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology (NCT03366142) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-02 |
Track LAD1 automatically
Every clearance here is in the API, with alerts when new ones post.